{"id":71400,"date":"2026-05-20T09:01:36","date_gmt":"2026-05-20T09:01:36","guid":{"rendered":"https:\/\/medsbase.com\/pinealon\/"},"modified":"2026-10-15T10:33:57","modified_gmt":"2026-10-15T10:33:57","slug":"pinealon","status":"publish","type":"product","link":"https:\/\/medsbase.com\/es\/product\/pinealon\/","title":{"rendered":"Pinealon"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Respuesta r\u00e1pida \u2014 \u00bfQu\u00e9 es Pinealon?<\/h3>\n<p style=\"margin: 0;\"><strong>Pinealon<\/strong> is a synthetic tripeptide (sequence Glu-Asp-Arg, EDR) belonging to the Khavinson short-peptide bioregulator family developed at the St. Petersburg Institute of Bioregulation and Gerontology. Originally derived from cattle pineal-gland-extract studies, Pinealon is studied for neuroprotective, anti-oxidant, and cognitive-aging effects in clinical models \u2014 with a proposed mechanism involving direct nuclear access and chromatin-level gene-expression regulation. Sibling peptide to <a href=\"https:\/\/medsbase.com\/es\/epitalon\/\">Epital\u00f3n<\/a> within the Khavinson series. Supplied in 5 mg, 10 mg, and 20 mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Qu\u00e9 obtienes con MedsBase:<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/es\/reviews\/\">opiniones de clientes<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Cada pedido est\u00e1 cubierto por nuestra <a href=\"https:\/\/medsbase.com\/es\/medsbase-re-shipment-assurance-policy\/\"><strong>Reshipment Assurance Policy<\/strong><\/a> \u2014 si tu paquete no llega en 20 d\u00edas laborables, lo reenviamos.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Especificaci\u00f3n<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detalle<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>N\u00famero CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">308067-43-8 (citado com\u00fanmente; no todas las fuentes de p\u00e9ptidos publican un n\u00famero de registro)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Tipo<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Synthetic tripeptide bioregulator (Khavinson short-peptide family) \u2014 developed at the St. Petersburg Institute of Bioregulation and Gerontology by Vladimir Khavinson; originally based on cattle pineal-gland extract studies. Pinealon is the cognitive \/ neuroprotective member of the Khavinson series, paired with <a href=\"https:\/\/medsbase.com\/es\/epitalon\/\">Epital\u00f3n<\/a> (longevidad\/telomerasa) como los dos compuestos m\u00e1s estudiados.<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>F\u00f3rmula molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>15<\/sub>H<sub>26<\/sub>N<sub>6<\/sub>O<sub>8<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Peso molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">~418.4 Da<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Secuencia<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">H-Glu-Asp-Arg-OH (EDR) \u2014 secuencia lineal de 3 residuos. Extremos N- y C-terminales libres; sin puente disulfuro, sin acilaci\u00f3n, sin PEGilaci\u00f3n. Carga neta +1 a pH neutro (un Arg cati\u00f3nico equilibrado con los grupos carboxilato de Glu\/Asp).<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forma<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Polvo liofilizado (blanco a blanquecino)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Pureza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (verificado por HPLC, COA bajo solicitud)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Almacenamiento<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Liofilizado: 2\u20138 \u00b0C (refrigerador) para stock de trabajo; \u221220 \u00b0C para almacenamiento a largo plazo de viales sin abrir. Reconstituido: 2\u20138 \u00b0C, usar en ~14\u201328 d\u00edas. Proteger de la luz. Evitar ciclos repetidos de congelaci\u00f3n-descongelaci\u00f3n de la soluci\u00f3n reconstituida.<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilidad<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Altamente soluble en agua bacteriost\u00e1tica o agua est\u00e9ril \u2014 los trip\u00e9ptidos cargados cortos se disuelven r\u00e1pidamente con agitaci\u00f3n suave. No se requieren disolventes especializados.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>\u00bfQu\u00e9 es Pinealon?<\/h2>\n<p><strong>Pinealon<\/strong> is a synthetic tripeptide consisting of L-glutamic acid, L-aspartic acid, and L-arginine (sequence Glu-Asp-Arg, single-letter code EDR). It is a member of the Khavinson short-peptide bioregulator family \u2014 a group of 2- to 4-amino-acid peptides developed at the St. Petersburg Institute of Bioregulation and Gerontology under Vladimir Khavinson, originally based on the fractionation and characterisation of bioactive material extracted from cattle pineal gland and other tissues. Within the Khavinson series, Pinealon is the compound most associated with cognitive function and neuroprotection in published studies, while its sibling tetrapeptide <a href=\"https:\/\/medsbase.com\/es\/epitalon\/\">Epital\u00f3n<\/a> (Ala-Glu-Asp-Gly, AEDG) is the most-studied compound in the longevity \/ telomerase context. Khavinson short peptides differ structurally from most other peptides in two important ways: <strong>son extremadamente cortos<\/strong> (Pinealon tiene solo tres residuos, PM ~418 Da, m\u00e1s peque\u00f1o que un f\u00e1rmaco de mol\u00e9cula peque\u00f1a t\u00edpico) y <strong>su mecanismo propuesto se centra en el acceso nuclear directo<\/strong> rather than receptor binding at the plasma membrane. The published Khavinson model holds that short charged peptides can cross both the cell membrane and the nuclear envelope, reach chromatin, and modulate gene expression through sequence-specific interactions with DNA \u2014 a mechanism distinct from the canonical receptor-binding pharmacology of larger peptides. This model is supported by published studies from the Khavinson group spanning several decades and is the subject of continued mechanistic investigation by independent users. Pinealon has been investigated in clinical contexts focused on cognitive aging, oxidative-stress protection of neuronal cultures, cerebral ischemia models, and circadian \/ pineal-axis studies. It is <strong>no est\u00e1 aprobado<\/strong> by the FDA, EMA, MHRA, or any other major regulator for human therapeutic use. <\/p>\n<h2>Mechanism of Action \u2014 Khavinson Short-Peptide Bioregulation<\/h2>\n<p>The published mechanistic model for Khavinson short peptides \u2014 supported by studies from the Khavinson group and tested in independent laboratories \u2014 proposes three principal modes of action:<\/p>\n<ul>\n<li><strong>Direct nuclear access and DNA-binding regulation of gene expression<\/strong> \u2014 Khavinson short peptides are proposed to traverse the plasma membrane and the nuclear envelope and reach chromatin directly. The published model holds that the short charged sequences (typically containing combinations of Glu \/ Asp \/ Arg \/ Lys residues) can engage in sequence-specific contacts with the major or minor groove of B-form DNA at promoter regions, modulating transcription of specific gene panels. Pinealon (Glu-Asp-Arg) has been linked in published work to upregulation of genes involved in antioxidant defense, mitochondrial function, and neuronal survival.<\/li>\n<li><strong>Anti-oxidant and mitochondrial-protective effects<\/strong> \u2014 In neuronal-culture and in-vivo rodent models, Pinealon administration is reported to reduce markers of reactive oxygen species (ROS), preserve mitochondrial membrane potential under stress (hyperoxia, hypoxia, glutamate excitotoxicity), and decrease apoptotic signalling. These effects are downstream of the gene-expression modulation rather than direct radical-scavenging.<\/li>\n<li><strong>Neuroprotection in cognitive-aging models<\/strong> \u2014 Behavioural studies in aged rodents have reported improvements in spatial-learning and working-memory performance after Pinealon administration relative to age-matched controls. The mechanism is interpreted as a combination of antioxidant protection of vulnerable neuronal populations (hippocampal CA1, cortical layer V) and direct gene-expression effects in neurons supporting synaptic plasticity machinery.<\/li>\n<\/ul>\n<p>Khavinson short peptides have very short plasma half-lives (minutes), but proposed effects persist for hours to days through downstream gene-expression cascades \u2014 a profile broadly similar to other receptor-trigger peptides where duration is set by signalling-cascade kinetics rather than by sustained plasma residence. Subcutaneous administration is the standard route in published studies protocols. <\/p>\n<h2>Published Evidence<\/h2>\n<p>Pinealon is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>Cognitive-aging studies<\/strong> \u2014 spatial learning, working memory, and behavioural performance in aged-rodent models; the most-studied application for Pinealon<\/li>\n<li><strong>Oxidative-stress protection of neuronal cultures<\/strong> \u2014 cortical and hippocampal primary-culture protection against H<sub>2<\/sub>O<sub>2<\/sub>, glutamate excitotoxicity, hyperoxia; ROS and mitochondrial-membrane-potential readouts<\/li>\n<li><strong>Cerebral ischemia \/ stroke models<\/strong> \u2014 ischemia-reperfusion injury in rodent middle-cerebral-artery occlusion (MCAO) models; infarct-volume and behavioural-deficit readouts<\/li>\n<li><strong>Neurodegenerative-disease in-vitro studies<\/strong> \u2014 Alzheimer-type A\u03b2-toxicity and Parkinson-type \u03b1-synuclein-toxicity models in cultured neurons; published work in PC12 and SH-SY5Y lines<\/li>\n<li><strong>Hypoxia and high-altitude studies<\/strong> \u2014 rendimiento cognitivo y conductual en condiciones hipob\u00e1ricas\/hip\u00f3xicas<\/li>\n<li><strong>Pineal-axis and circadian rhythm support<\/strong> \u2014 historical pineal-gland-extract origin makes Pinealon a tool for examining pineal-axis modulation of circadian gene expression, though most current studies focuses on neuroprotection rather than circadian rhythm per se<\/li>\n<li><strong>Farmacolog\u00eda comparativa de p\u00e9ptidos de Khavinson<\/strong> \u2014 comparaci\u00f3n directa con <a href=\"https:\/\/medsbase.com\/es\/epitalon\/\">Epital\u00f3n<\/a> (AEDG, longevidad\/telomerasa), Vilon (KE, inmunidad) y Livagen (KEDA, hepatoprotecci\u00f3n) para analizar la especificidad de secuencia de los efectos de los p\u00e9ptidos cortos<\/li>\n<\/ul>\n<p>For broader context on neuroactive short peptides and related compounds, see <a href=\"https:\/\/medsbase.com\/es\/epitalon\/\">Epital\u00f3n<\/a> (tetrap\u00e9ptido hermano de Khavinson), <a href=\"https:\/\/medsbase.com\/es\/semax\/\">Semax<\/a> (heptap\u00e9ptido derivado de ACTH, mejora cognitiva), <a href=\"https:\/\/medsbase.com\/es\/selank\/\">Selank<\/a> (ansiol\u00edtico\/nootr\u00f3pico derivado de tuftsina) y <a href=\"https:\/\/medsbase.com\/es\/dsip\/\">DSIP<\/a> (p\u00e9ptido inductor del sue\u00f1o delta). Explore el <a href=\"https:\/\/medsbase.com\/es\/peptides\/\">cat\u00e1logo de p\u00e9ptidos<\/a> para compuestos relacionados. <\/p>\n<h2>Concentraciones y potencias disponibles<\/h2>\n<p>MedsBase stocks Pinealon in three lyophilized vial sizes calibrated to typical protocol lengths. Each strength is available in 10-vial, 20-vial, or 30-vial pack formats:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Potencia del vial<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Caso de uso t\u00edpico<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Tama\u00f1os de paquete<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Dosificaci\u00f3n piloto \u2014 protocolos cortos de envejecimiento cognitivo, titulaci\u00f3n de dosis-respuesta, trabajo in vitro sobre estr\u00e9s oxidativo<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 o 30 viales<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength \u2014 multi-week cognitive-aging studies, MCAO ischemia models, multi-cohort protocols<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 o 30 viales<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>20 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Protocolos de ciclo extendido \u2014 estudios de envejecimiento a largo plazo, trabajo conductual con grandes cohortes, menor costo por mg<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 o 30 viales<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>All three strengths are the same chemical form (lyophilized powder, \u226599% HPLC purity). Published studies protocols use a wide dose range depending on model and route \u2014 typically 100 \u00b5g\u20134 mg per kg body weight in rodent models. Determine dose ranges from peer-reviewed literature appropriate to your specific protocol. <\/p>\n<h2>Comparativa \u2014 Pinealon frente a Epitalon<\/h2>\n<p>Pinealon y <a href=\"https:\/\/medsbase.com\/es\/epitalon\/\">Epital\u00f3n<\/a> are the two most-studied compounds in the Khavinson short-peptide family. Both are short charged peptides developed by the same group and share the proposed direct-nuclear-access mechanism, but they have entirely different sequence specificity and different best-studied applications. <\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Criterio<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Pinealon<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Epital\u00f3n<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Secuencia<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Glu-Asp-Arg (EDR)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Ala-Glu-Asp-Gly (AEDG)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Longitud<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">3 amino\u00e1cidos (trip\u00e9ptido)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">4 amino\u00e1cidos (tetrap\u00e9ptido)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Peso molecular<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~418 Da<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~390 Da<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Carga neta<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">+1 (Arg equilibra Glu\/Asp)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u22122 (Glu\/Asp dominan; sin residuos cati\u00f3nicos)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Best-studied studies focus<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Envejecimiento cognitivo, neuroprotecci\u00f3n, protecci\u00f3n contra el estr\u00e9s oxidativo en cultivos neuronales<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Telomerase activation, lifespan extension, longevity studies<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Origen tisular (propuesto)<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Fraccionamiento de extracto de gl\u00e1ndula pineal bovina<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Fraccionamiento de extracto de gl\u00e1ndula pineal bovina<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Mecanismo propuesto<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Acceso nuclear directo; modulaci\u00f3n de la expresi\u00f3n g\u00e9nica antioxidante y mitocondrial<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Acceso nuclear directo; uni\u00f3n propuesta al promotor de la telomerasa<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Vida media plasm\u00e1tica<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Minutos (el efecto persiste a trav\u00e9s de cascadas descendentes)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Minutos (el efecto persiste a trav\u00e9s de cascadas descendentes)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For studies focused on neuroprotection, cognitive-aging models, or oxidative-stress protection of neuronal cultures, Pinealon is the more targeted Khavinson peptide. For studies focused on telomerase activation, replicative-senescence reversal, or longevity-axis pharmacology, <a href=\"https:\/\/medsbase.com\/es\/epitalon\/\">Epital\u00f3n<\/a> remains the more widely-studied option. Some protocols use both compounds in parallel to dissect the sequence-specificity of Khavinson short-peptide effects. <\/p>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 14px 18px; margin: 18px 0;\"><strong class=\"mb-bac-water-callout\">\ud83d\udca7 \u00bfNecesitas agua BAC?<\/strong> La reconstituci\u00f3n de cualquier vial liofilizado requiere agua bacteriost\u00e1tica est\u00e9ril. Combina este producto con nuestro <a href=\"\/es\/bac-water\/\"><strong>Agua BAC (Agua Bacteriost\u00e1tica)<\/strong><\/a> \u2014 vial multidosis de 30 mL, conservado con alcohol benc\u00edlico 0.9%, grado USP.<\/div>\n<h2>Almacenamiento y reconstituci\u00f3n<\/h2>\n<p><strong>Antes de la reconstituci\u00f3n:<\/strong> almacena los viales liofilizados refrigerados a 2\u20138 \u00b0C en su envase original para stock de trabajo a corto plazo. Para almacenamiento a largo plazo, congela los viales sin abrir a \u221220 \u00b0C. Pinealon liofilizado es estable bajo refrigeraci\u00f3n hasta 24 meses y a \u221220 \u00b0C hasta 36 meses. Evita ciclos de congelaci\u00f3n-descongelaci\u00f3n del polvo liofilizado. Pinealon es un trip\u00e9ptido corto no modificado sin puente disulfuro ni cadena acilo \u2014 su manipulaci\u00f3n es de las m\u00e1s sencillas del cat\u00e1logo. <strong>Procedimiento de reconstituci\u00f3n:<\/strong> inyecta el agua bacteriost\u00e1tica por la pared lateral del vial (no directamente sobre el polvo liofilizado). Para un vial de 10 mg, 2.0 mL de agua bacteriost\u00e1tica producen una concentraci\u00f3n de trabajo de 5 mg\/mL; 1.0 mL produce un stock de 10 mg\/mL. Para un vial de 5 mg, 1.0 mL de agua bacteriost\u00e1tica produce un stock de trabajo de 5 mg\/mL. Para un vial de 20 mg, 2.0 mL producen un stock de trabajo de 10 mg\/mL. Agita suavemente \u2014 no agites vigorosamente, ya que la espuma atrapa aire y puede alterar las cadenas pept\u00eddicas. Permite que el polvo se disuelva completamente (normalmente &lt;1 minuto para Pinealon) antes de extraer. Una vez reconstituido, almacena el vial a 2\u20138 \u00b0C y \u00fasalo en 14\u201328 d\u00edas. Protege de la luz. Desecha si aparece turbidez, part\u00edculas o cambio de color. <\/p>\n<h2>Preguntas frecuentes<\/h2>\n<h3>\u00bfQu\u00e9 es la familia de p\u00e9ptidos cortos de Khavinson y por qu\u00e9 Pinealon forma parte de ella?<\/h3>\n<p>The Khavinson short-peptide family is a series of 2- to 4-amino-acid peptides developed at the St. Petersburg Institute of Bioregulation and Gerontology by Vladimir Khavinson and colleagues, starting in the 1970s. The original studies extracted bioactive material from various cattle tissues (pineal, thymus, prostate, retina, etc.) and identified short peptide fragments responsible for tissue-specific bioregulatory effects. Pinealon (Glu-Asp-Arg) is the cognitive \/ neuroprotective compound in this series; <a href=\"https:\/\/medsbase.com\/es\/epitalon\/\">Epital\u00f3n<\/a> (Ala-Glu-Asp-Gly) es el compuesto de longevidad\/activaci\u00f3n de telomerasa; Vilon, Livagen, Thymogen y otros tienen como objetivo otros tejidos. <\/p>\n<h3>\u00bfEn qu\u00e9 se diferencia Pinealon de Epitalon?<\/h3>\n<p>Both are short Khavinson peptides extracted from cattle pineal-gland studies, but they have different sequences and different best-studied applications. Pinealon (Glu-Asp-Arg, tripeptide, +1 net charge) is studied for cognitive aging and neuroprotection. <a href=\"https:\/\/medsbase.com\/es\/epitalon\/\">Epital\u00f3n<\/a> (Ala-Glu-Asp-Gly, tetrap\u00e9ptido, carga neta \u22122) se estudia para activaci\u00f3n de telomerasa y extensi\u00f3n de vida \u00fatil. La carga neta opuesta es una raz\u00f3n estructural por la que los dos p\u00e9ptidos se dirigen a diferentes loci gen\u00f3micos bajo el mecanismo propuesto de uni\u00f3n directa al ADN. <\/p>\n<h3>\u00bfCu\u00e1l es el mecanismo propuesto de los p\u00e9ptidos cortos de Khavinson?<\/h3>\n<p>The published Khavinson model holds that short charged peptides can cross the cell membrane and nuclear envelope, reach chromatin, and modulate gene expression through sequence-specific contacts with the DNA double helix at promoter regions. This is distinct from the canonical receptor-binding mechanism of larger peptides. The model is supported by studies from the Khavinson group spanning several decades and is the subject of continued mechanistic investigation by independent users. <\/p>\n<h3>\u00bfQu\u00e9 tan corto puede ser un p\u00e9ptido y seguir siendo biol\u00f3gicamente activo?<\/h3>\n<p>Pinealon at 3 amino acids is among the shortest pharmacologically-active peptides known. Even shorter examples exist (the dipeptide carnosine, the GLP-1 fragments, dipeptide HSP modulators), but most peptides are longer (10\u201340+ residues). The Khavinson short-peptide series is a focused area of studies specifically because the very short sequences allow rapid synthesis, easy crossing of cellular barriers, and clean structure-activity dissection. <\/p>\n<h3>\u00bfPor qu\u00e9 la vida media plasm\u00e1tica de Pinealon es tan corta?<\/h3>\n<p>Los p\u00e9ptidos cortos cargados son r\u00e1pidamente eliminados por filtraci\u00f3n glomerular y prote\u00f3lisis. Pinealon tiene una vida media plasm\u00e1tica de solo minutos \u2014 sin embargo, los efectos propuestos (modulaci\u00f3n de expresi\u00f3n g\u00e9nica, protecci\u00f3n antioxidante, mejora conductual) persisten durante horas o d\u00edas a trav\u00e9s de cascadas de se\u00f1alizaci\u00f3n posteriores. Este perfil es similar a otros p\u00e9ptidos desencadenantes de receptores donde la duraci\u00f3n est\u00e1 determinada por la cin\u00e9tica de la cascada de se\u00f1ales m\u00e1s que por la residencia plasm\u00e1tica sostenida. <\/p>\n<h3>What is the typical dose of Pinealon in rodent models?<\/h3>\n<p>Published rodent-model dose ranges span approximately 100 \u00b5g\u20134 mg per kg body weight per day, depending on route (subcutaneous most common), model (cognitive aging, MCAO, oxidative stress), and study duration. Subcutaneous administration is the standard administration route. Determine dose ranges from peer-reviewed literature appropriate to your specific protocol. <\/p>\n<h3>\u00bfTiene Pinealon efectos fuera del SNC?<\/h3>\n<p>Pinealon is best-studied in CNS contexts (cognitive aging, neuroprotection, cerebral ischemia), but the proposed mechanism \u2014 direct nuclear access and gene-expression modulation \u2014 is in principle tissue-independent. Some published studies has examined peripheral effects (anti-oxidant in hepatic and renal models, immunomodulation in mixed-cell-culture systems), but the bulk of the literature centres on CNS readouts. <\/p>\n<h3>\u00bfExiste documentaci\u00f3n establecida con n\u00famero de registro CAS para Pinealon?<\/h3>\n<p>El CAS 308067-43-8 es el n\u00famero de registro m\u00e1s citado en los cat\u00e1logos de proveedores de p\u00e9ptidos, pero a diferencia de <a href=\"https:\/\/medsbase.com\/es\/epitalon\/\">Epital\u00f3n<\/a> (which has a well-documented CAS 307297-39-8 across major reference databases), Pinealon&#8217;s CAS registration is less authoritatively published. Users requiring a regulatory-grade authoritative reference should verify against current CAS Registry sources. <!-- medsbase-related-alts-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Bioregulador pept\u00eddico corto de Khavinson (trip\u00e9ptido EDR)<br \/>\n\u2705 Propuesto acceso nuclear directo + se\u00f1alizaci\u00f3n a nivel de cromatina<br \/>\n\u2705 Estudiado en modelos de envejecimiento cognitivo y neuroprotecci\u00f3n<br \/>\n\u2705 Antioxidante + protector mitocondrial en cultivos neuronales<br \/>\n\u2705 Relacionado con Epitalon (p\u00e9ptido de longevidad)<\/p>\n<p><strong>Pinealon<\/strong> contiene compuesto de p\u00e9ptido sint\u00e9tico.<\/p>","protected":false},"featured_media":71407,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[6468,6467,5441,6466],"class_list":["post-71400","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-edr","product_tag-khavinson","product_tag-peptide","product_tag-pinealon","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product\/71400","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/comments?post=71400"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/media\/71407"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/media?parent=71400"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product_brand?post=71400"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product_cat?post=71400"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product_tag?post=71400"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}